SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-003010
Filing Date
2018-01-09
Accepted
2018-01-09 18:03:45
Documents
2
Period of Report
2018-01-05

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1524
2 POA DOCUMENT poa.txt EX-24.3_761919 3123
  Complete submission text file 0001209191-18-003010.txt   6131
Mailing Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306
Business Address 350 CAMBRIDGE AVE SUITE 350 PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Issuer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address RIGEL PHARMACEUTICALS, INC. 1180 VETERANS BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
Mayer Eldon C. III (Reporting) CIK: 0001686952 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36183 | Film No.: 18519951